Extracorporal blood purification: More than diffusion and convection. Does this help?

Current Opinion in Critical Care

Volumn 13, Issue 6, 2007, Pages 662-667

  Ronco, Claudio ^a   Tetta, Ciro ^b,c  

^a SAN BORTOLO HOSPITAL   (Italy)

^b FRESENIUS MEDICAL CARE   (Germany)

^c International Research and Development   (Germany)

Author keywords

Adsorption; Convection; Diffusion; Liver failure; Renal failure; Sepsis

Indexed keywords

ADSORBENT; ALBUMIN; AMMONIA; BICARBONATE; BILE ACID; BILIRUBIN; CREATININE; PROTHROMBIN; UREA;

ADSORPTION; BIOCOMPATIBILITY; DIALYSATE; DIFFUSION; HEMODIALYSIS; HEMOFILTRATION; HEMOPERFUSION; HUMAN; KIDNEY FAILURE; LIVER FAILURE; PARTICLE SIZE; POROSITY; REVIEW; SEPSIS; SEPTIC SHOCK; SOLUTE;

ADSORPTION; ALBUMINS; CONVECTION; DIFFUSION; HEMOPERFUSION; HUMANS; KIDNEY FAILURE, ACUTE; LIVER FAILURE; RENAL DIALYSIS; SEPSIS;

EID: 35848955864     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3282f194c0     Document Type: Review

References (34)

1. Ronco C, Bellomo R, Honoré P, et al. Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356:26-30.
2. Bellomo R. Do we know the optimal dose for renal replacement therapy in the intensive care unit? Kidney Int 2006; 70:487-498. This is a review of the evidence for an optimal dose for extracorporeal treatments in acute renal failure.
3. Honoré PM, Joannes-Boyau O, Gressens B. Blood and plasma treatments - the rationale of high volume haemofiltration. Contrib Nephrol 2007;156:371-386. This is an excellent and comprehensive review on highly convective treatments. It ties together the findings of numerous previous studies and presents the scenario for future developments of this technique.
4. Ratanarat R, Brendolan A, Piccinni P, et al. Pulse high-volume haemofiltration for treatment of severe sepsis. Effects on haemodynamics and survival. Crit Care 2005; 4:R294-R302.
5. Reeves JH, Butt WW, Shann F, et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999;27:2096-2104.
6. Tetta C, Bellomo R, Formica M, et al. Use of adsorbents in ARF therapy. Contrib Nephrol 2002; 137:1-8.
7. Bellomo R, Tetta C, Ronco C. Coupled plasma filtration adsorption. Intensive Care Med 2006; 29:1222-1228. A state-of-art, comprehensive review of the rationale and supportive studies on the role of adsorbents in blood-purification techniques.
8. Yatzidis H. A convenient hemoperfusion microapparatus over charcoal for the treatment of endogenous and exogenous intoxification: its use as an effective artificial kidney. Proc Eur Dial Transplant Assoc 1964;1:83-87.
9. La Greca G, Brendolan A, Ghezzi PM, et al. The concept of sorbents in hemodialysis. Int J Artif Organs 1998; 21:303-308.
10. De Nitti C, Giordano R, Gervasio R, et al. Choosing new adsorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution. Int J Artif Organs 2001; 24:765-776.
11. Winchester JF, Silberzweig J, Ronco C, et al. Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal. Blood Purif 2004; 22:73-77.
12. Santoro A, Mancini E, Fieramosca E, Faenza S. Liver support systems. Contrib Nephrol 2007; 156:396-404. This is a comprehensive review on the kinetics of bilirubin and practical approaches to extracorporeal therapies in liver failure.
13. Kellum J, Song M, Venkataran M. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32:801-805.
14. Stange J, Hassanein TI, Mehta R, et al. The molecular adsorbent recycling system (as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective rabdomized, controlled clinical trial, and clinical experience from 19 centres). Artif Organs 2002; 26:103-110.
15. Strobl W, Vogt G, Mitteregger R, et al. The Fractionated Plasma Separation and Adsorption System (FPSA), a new membrane filtration-adsorption system in the extracorporeal blood purification in liver disease [in German]. Ergänzungsband 1998; 1:168-169.
16. Falkenhagen D, Strobl W, Vogt G, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999; 23:81-86.
17. Weber C, Strobl W, Krause A, Falkenhagen D. A novel detoxification device for the treatment of hepatic failure (HF). ASAIO J 2002; 48:181-184.
18. Krause A. Prometheus - a new extracorporeal liver support therapy. In: Arroyo V, Forns X, Garcia-Pagán JC, Rodés J, editors. Progress in the Treatment of Liver, Diseases. Barcelona: Ars Medica; 2003. pp. 437-443.
19. Krisper P, Stauber RE. Technology insight: artificial extracorporeal liver support - how does Prometheus compare with MARS? Nat Clin Practice Nephrol 2007; 3:267-276. This is an exhaustive review of the concept of MARS and Prometheus, and of their relative removal efficiencies and clinical impact.
20. Evenpoel P, Laleman W, Wilmer A, et al. Prometheus versus Molecular Adsorbents Recirculating System: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006; 30:276-284. An extensive review that deals with both the relative mechanisms and the detoxification efficiencies of the two techninques.
21. Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Md 2002; 30:1250-1255.
22. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365:63-78.
23. Tetta C, Cavaillon JM, Schultze M, et al. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 1998; 13:1458-1464.
24. Ronco C, Tetta C, Mariano, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Org 2003; 27:792-801.
25. Stange J, Hassanein TI, Mehta R, et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomised, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26:103-110.
26. Ichai P, Samuel D. Extracorporeal liver support with MARS in liver failure: has it a role in the treatment of severe alcoholic hepatitis? J Hepatol 2003; 38:104-106.
27. Stadbauer V, Krisper P, Beuers U, et al. Removal of bile acids by two different extracorporeal systems in acute-on-chronic liver failure. ASAIO J 2007; 53:187-193.
28. Rifai K, Ernst T, Kretchmer U, et al. Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatology 2003; 39:984-990.
29. Herget-Rosenthal S. Citrate anticoagulated modified fractionated plasma separation and adsorption: first clinical efficacy and safety data in liver failure. J Am Soc Nephrol 2003; 14:729A.
30. Kramer L, Bauer E, Schenk P, et al. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 2003; 115:599-603.
31. Rifai K, Hafer C, Rosenau J, et al. Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®). Scand J Gastroenterol 2006; 41:1212-1217. The authors discribed the relevant role of subsequent sessions with Prometheus in the treatment of intractable pruritus.
32. Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43:451-457.
33. Sauer IM, Goetz M, Steffen I, et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39:1408-1414.
34. Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic hemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10:R108. This is a carefully conducted study on the effect of the MARS and Prometheus devices on the hemodynamics and vasoactive hormones, performed on 18 patients with acute-on-chronic alcoholic liver failure.